Versant Venture Capital VI, L.P. - 19 Sep 2025 SCHEDULE 13D/A Report for LAVA Therapeutics N.V. Common Shares, par value Euro 0.12 per share (LVTX)

Filing Manager: Versant Venture Capital VI, L.P.
Reporting Manager: Versant Venture Capital VI, L.P.
Security: LAVA Therapeutics N.V. Common Shares, par value Euro 0.12 per share
Symbol: LVTX
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13D/A
Filing time: 23 Sep 2025, 16:52:44 UTC
Date of event: 19 Sep 2025
Previous filing: 18 Sep 2025
SEC: View on sec.gov

Reporting Managers (6)

Name	Ownership	Signature	Title	CIK
Versant Venture Capital VI, L.P.	0%	/s/Max Eisenberg	Max Eisenberg/COO of Versant Ventures VI GP-GP, LLC, the GP of Versant Ventures VI GP, L.P., the GP of Versant Venture Capital VI, L.P.	0001687880
Versant Ventures VI GP, L.P.	0%	/s/Max Eisenberg	Max Eisenberg/COO of Versant Ventures VI GP-GP, LLC, the GP of Versant Ventures VI GP, L.P., the GP of Versant Venture Capital VI, L.P.	0001777654
Versant Ventures VI GP-GP, LLC	0%	/s/Max Eisenberg	Max Eisenberg/COO of Versant Ventures VI GP-GP, LLC, the GP of Versant Ventures VI GP, L.P., the GP of Versant Venture Capital VI, L.P.	0001777652
Versant Vantage I, L.P.	0%	/s/Max Eisenberg	Max Eisenberg/COO of Versant Vantage I GP-GP, LLC, the GP of Versant Vantage I GP, L.P., the GP of Versant Vantage I, L.P.
Versant Vantage I GP, L.P.	0%	/s/Max Eisenberg	Max Eisenberg/COO of Versant Vantage I GP-GP, LLC, the GP of Versant Vantage I GP, L.P., the GP of Versant Vantage I, L.P.
Versant Vantage I GP-GP, LLC	0%	/s/Max Eisenberg	Max Eisenberg/COO of Versant Vantage I GP-GP, LLC, the GP of Versant Vantage I GP, L.P., the GP of Versant Vantage I, L.P.